Ultragenyx Pharmaceutical

Filed a patent for "compositions and methods for treating conditions associated with bsep deficiency" on Wed, July 26, 2023

Filed a patent for "compositions and methods for reducing host cell proteins in recombinant adeno-associated virus preparations" on Fri, June 23, 2023

Filed a patent for "method of producing soluble microdystrophin protein and uses of the same" on Fri, December 23, 2022

Filed a patent for "crystalline forms of sialic acid derivatives and methods for their use" on Fri, February 17, 2023

Filed a patent for "human fgf23-binding antibodies with improved affinity and efficacy" on Fri, March 10, 2023

Filed a patent for "formulations comprising recombinant aav and methods of administering the same" on Thu, May 18, 2023

Filed a patent for "human fgf23-binding antibodies with improved affinity and efficacy" on Tue, July 18, 2023

Filed a patent for "human fgf23-binding antibodies with improved affinity and efficacy" on Thu, February 1, 2024

Filed a patent for "gene therapy for treating cdkl5 deficiency disorder" on Thu, February 23, 2023

Filed a patent for "intensified perfusion systems and methods for aav production" on Tue, August 16, 2022

Filed a patent for "methods for enhancing recombinant adeno-associated virus yield" on Thu, April 27, 2023

Filed a patent for "modified batch aav production systems and methods" on Wed, January 25, 2023

Filed a patent for "solid compositions of triglycerides and uses thereof" on Thu, June 15, 2023

Filed a patent for "dux4 inhibitors and methods of use thereof" on Thu, November 2, 2023

Filed a patent for "anion-exchange chromatography methods for separation of empty from full recombinant adeno-associated virus particles" on Fri, June 9, 2023

Filed a patent for "creatine prodrugs, compositions and methods of use thereof" on Thu, March 21, 2024

Filed a patent for "effective and efficient control of serum phosphate for optimal bone formation" on Thu, April 11, 2024

Filed a patent for "methods for improved therapeutic use of recombinant aav" on Thu, November 3, 2022

Filed a patent for "creatine prodrugs, compositions and methods of use thereof" on Thu, July 21, 2022

Filed a patent for "therapeutics for glycogen storage disease type iii" on Thu, October 27, 2022

Filed a patent for "chaotropic agents for reducing formation of double-stranded rna" on Thu, March 16, 2023

Filed a patent for "novel anion-exchange chromatography methods for separation of empty from full recombinant adeno-associated virus particles" on Fri, August 12, 2022

Filed a patent for "methods and compositions for the treatment of amyloidosis" on Thu, April 27, 2023

Filed a patent for "methods of using anti-sclerostin antibodies in treatment of osteogenesis imperfecta" on Thu, September 8, 2022